Record of Stakeholder Meeting - Eculizumab (Soliris®) for Atypical Haemolytic Uraemic Syndrome (February 2016)

Page last updated: 22 April 2016

A clinical advice meeting was held on 12 February 2016 to discuss the place of eculizumab (Soliris) for the treatment of atypical haemolytic uraemic syndrome (aHUS) in the context of renal transplantation.